Validation of a dissolution method with HPLC analysis for lasofoxifene tartrate low dose tablets

Journal of Pharmaceutical and Biomedical Analysis

Volumn 44, Issue 5, 2007, Pages 1064-1071

  Space, J Sean ^a   Opio, Alex M ^a   Nickerson, Beverly ^a   Jiang, Hong ^a   Dumont, Monica ^a   Berry, Mark ^a  

^a PFIZER INC   (United States)

Author keywords

Dissolution; HPLC; Intermediate precision; Low dose tablet; Method robustness; Statistical design; Validation

Indexed keywords

LASOFOXIFENE;

ACCURACY; ANALYTIC METHOD; ARTICLE; DISSOLUTION; DRUG STABILITY; DRUG STRUCTURE; EXPERIMENTAL DESIGN; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOW DRUG DOSE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TABLET FORMULATION; VALIDATION PROCESS;

CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGEN RECEPTOR MODULATORS; MOLECULAR STRUCTURE; PYRROLIDINES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOLUBILITY; TABLETS; TECHNOLOGY, PHARMACEUTICAL; TETRAHYDRONAPHTHALENES; TIME FACTORS;

EID: 34547749328     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.04.032     Document Type: Article

References (14)

1. ICH-Q2A Guideline for Industry, Text on Validation of Analytical Procedures, March 1995.
2. Guidance for Industry, Q2B Validation of Analytical Procedures: Methodology, November 1996.
3. Kaniwa N., and Ojima Y. Pharm. Tech. Japan 16 (2000) 171-179
4. Kojima S. Pharm. Tech. Japan 18 (2002) 695-704
5. Likar M.L., Mansour H.L., and Harwood J.W. J. Pharm. Biomed. Anal. 39 (2005) 543-551
6. Breier A.R., Paim C.S., Steppe M., and Schapoval E.E. J. Pharm. Pharm. Sci. 8 (2005) 289-298
7. Ficarra R., Calabro M.L., Cutroneo P., Tommasini S., Melardi S., Semreen M., Furlanetto S., Ficarra P., and Altavilla G. J. Pharm. Biomed. Anal. 29 (2002) 1097-1103
8. Guo J.H., Harcum W.W., Skinner G.W., Dluzneski P.R., and Trumbull D.E. Drug Dev. Ind. Pharm. 26 (2000) 337-342
9. Tzanavaras P.D., Verdoukas A., and Balloma T. J. Pharm. Biomed. Anal. 41 (2006) 437-441
10. Bloomfield M.S., and Butler W.C. Int. J. Pharm. 206 (2000) 55-61
11. Gennari L., Merlotti D., Martini G., and Nuti R. Expert Opin. Investig. Drugs 15 (2006) 1091-1103
12. Gennari L. Drugs Today 42 (2006) 355-367
13. Drug Approval and Licensing Procedures in Japan, Yakugyo Jiho Co., Ltd., 1998.
14. Dissolution Testing of Immediate Release Solid Oral Dosage Forms, US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Guidance for Industry, August 1997.